GeneDx Holdings Corp - Class A
Research GeneDx Holdings Corp - Class A (WGS) on Bullrun: market cap USD 2.05B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWGS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 2.05B
- Financial periodFY2025
- RevenueUSD 427.54M
- Revenue growth40.0%
- Net income-USD 21.00M
- Free cash flowUSD 14.26M
- Gross margin69.7%
Valuation Snapshot
latest market cap is USD 2.05B.
About GeneDx Holdings Corp - Class A
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Frequently asked questions
What is GeneDx Holdings Corp - Class A's market cap?
GeneDx Holdings Corp - Class A's market capitalization is USD 2.05B.
What does GeneDx Holdings Corp - Class A do?
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.